MI
HRTX icon

Motiv8 Investments’s Heron Therapeutics HRTX Stock Holding History

Motiv8 Investments’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-69,245
Closed -$87.2K – 948
2025
Q3 		$87.2K Hold
69,245
– – 0.05% 104
2025
Q2 		$143K Hold
69,245
– – 0.09% 91
2025
Q1 		$152K Hold
69,245
– – 0.1% 93
2024
Q4 		$106K Sell
69,245
-8,401
-11% -$13.6K 0.07% 89
2024
Q3 		$155K Sell
77,646
-34
-0% -$81 0.1% 85
2024
Q2 		$272K Sell
77,680
-37
-0% -$114 0.2% 77
2024
Q1 		$215K Sell
77,717
-14
-0% -$35 0.17% 78
2023
Q4 		$132K Buy
+77,731
New +$85.6K 0.12% 94

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Motiv8 Investments's HRTX Position: Q4 2025 in Review

Motiv8 Investments sold out of Heron Therapeutics (HRTX) in Q4 2025, closing a stake of 69,245 shares — an estimated $87.2K sold.

Motiv8 Investments first reported a position in HRTX in Q4 2023 and held it in 8 quarters. The position peaked at $272K in Q2 2024. 170 funds tracked by Wall St. Rank hold HRTX as of Q4 2025.

  • Motiv8 Investments reported no remaining Heron Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Motiv8 Investments sold 69,245 Heron Therapeutics shares in Q4 2025, an estimated $87.2K.
  • Motiv8 Investments first reported a position in Heron Therapeutics in Q4 2023 and held it in 8 quarters.
  • Motiv8 Investments's Heron Therapeutics position peaked at $272K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.